Literature DB >> 22019851

Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors.

Hiroki Hagiwara1, Fumiaki Saito, Toshihiro Masaki, Miki Ikeda, Ayami Nakamura-Ohkuma, Teruo Shimizu, Kiichiro Matsumura.   

Abstract

Histone deacetylase inhibitors (HDACIs) are known to promote skeletal muscle formation. However, their mechanisms that include effects on the expression of major muscle components such as the dystrophin-associated proteins complex (DAPC) or myogenic regulatory factors (MRFs) remain unknown. In this study, we investigated the effects of HDACIs on skeletal muscle formation using the C2C12 cell culture system. C2C12 myoblasts were exposed to trichostatin A (TSA), one of the most potent HDACIs, and differentiation was subsequently induced. We found that TSA enhances the expression of myosin heavy chain without affecting DAPC expression. In addition, TSA increases the expression of the early MRFs, Myf5 and MEF2, whereas it suppresses the expression of the late MRF, myogenin. Interestingly, TSA also enhances the expression of Id1, Id2, and Id3 (Ids). Ids are myogenic repressors that inhibit myogenic differentiation. These findings suggest that TSA promotes gene expression in proliferation and suppresses it in the differentiation stage of muscle formation. Taken together, our data demonstrate that TSA enhances myogenesis by coordinating the expression of MRFs and myogenic repressors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019851     DOI: 10.1016/j.bbrc.2011.10.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Regulation of AURKC expression by CpG island methylation in human cancer cells.

Authors:  Satoshi Fujii; Vibhuti Srivastava; Apurva Hegde; Yutaka Kondo; Lanlan Shen; Koyu Hoshino; Yvette Gonzalez; Jin Wang; Kaori Sasai; Xiaotu Ma; Hiroshi Katayama; Marcos R Estecio; Stanley R Hamilton; Ignacio Wistuba; Jean-Pierre J Issa; Subrata Sen
Journal:  Tumour Biol       Date:  2015-05-20

2.  Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model.

Authors:  Gabriela P de Oliveira; Jessica R Maximino; Mariana Maschietto; Edmar Zanoteli; Renato D Puga; Leandro Lima; Dirce M Carraro; Gerson Chadi
Journal:  Cell Mol Neurobiol       Date:  2014-01-18       Impact factor: 5.046

3.  Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice.

Authors:  Katherine V Bricceno; Paul J Sampognaro; James P Van Meerbeke; Charlotte J Sumner; Kenneth H Fischbeck; Barrington G Burnett
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

4.  The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells.

Authors:  J Zych; M A Stimamiglio; A C Senegaglia; P R S Brofman; B Dallagiovanna; S Goldenberg; A Correa
Journal:  Braz J Med Biol Res       Date:  2013-05       Impact factor: 2.590

5.  In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model.

Authors:  Kazushi Ikeda; Akira Ito; Ryusuke Imada; Masanori Sato; Yoshinori Kawabe; Masamichi Kamihira
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

6.  Histone deacetylase activity mediates thermal plasticity in zebrafish (Danio rerio).

Authors:  Frank Seebacher; Alec I M Simmonds
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

7.  High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy.

Authors:  Emanuele Loro; Kasturi Sengupta; Sasha Bogdanovich; Kanupriya Whig; David C Schultz; Donna M Huryn; Tejvir S Khurana
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

8.  Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Teuta Domi; Emanuela Porrello; Daniele Velardo; Alessia Capotondo; Alessandra Biffi; Rossana Tonlorenzi; Stefano Amadio; Alessandro Ambrosi; Yuko Miyagoe-Suzuki; Shin'ichi Takeda; Markus A Ruegg; Stefano Carlo Previtali
Journal:  Skelet Muscle       Date:  2015-09-03       Impact factor: 4.912

9.  MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate.

Authors:  Lena Smirnova; Katharina Block; Alexandra Sittka; Michael Oelgeschläger; Andrea E M Seiler; Andreas Luch
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

10.  Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy.

Authors:  Justin G Boyer; Marc-Olivier Deguise; Lyndsay M Murray; Armin Yazdani; Yves De Repentigny; Céline Boudreau-Larivière; Rashmi Kothary
Journal:  Hum Mol Genet       Date:  2014-04-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.